188 related articles for article (PubMed ID: 2501083)
21. Survival and death of prelymphomatous B-cells from N-myc/bcl-2 double transgenic mice correlates with the regulation of intracellular Ca2+ fluxes.
Zörnig M; Busch G; Beneke R; Gulbins E; Lang F; Ma A; Korsmeyer S; Möröy T
Oncogene; 1995 Nov; 11(10):2165-74. PubMed ID: 7478538
[TBL] [Abstract][Full Text] [Related]
22. Regulated activity of the IgH intron enhancer (E mu) in the T lymphocyte lineage.
Cook GP; Meyer KB; Neuberger MS; Pettersson S
Int Immunol; 1995 Jan; 7(1):89-95. PubMed ID: 7718518
[TBL] [Abstract][Full Text] [Related]
23. In a model of immunoglobulin heavy-chain (IGH)/MYC translocation, the Igh 3' regulatory region induces MYC expression at the immature stage of B cell development.
Yan Y; Park SS; Janz S; Eckhardt LA
Genes Chromosomes Cancer; 2007 Oct; 46(10):950-9. PubMed ID: 17639584
[TBL] [Abstract][Full Text] [Related]
24. Surface IgM mediated regulation of RAG gene expression in E mu-N-myc B cell lines.
Ma A; Fisher P; Dildrop R; Oltz E; Rathbun G; Achacoso P; Stall A; Alt FW
EMBO J; 1992 Jul; 11(7):2727-34. PubMed ID: 1628630
[TBL] [Abstract][Full Text] [Related]
25. Immunoglobulin heavy chain enhancer is located near or in an initiation zone of chromosomal DNA replication.
Ariizumi K; Wang Z; Tucker PW
Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3695-9. PubMed ID: 8475117
[TBL] [Abstract][Full Text] [Related]
26. The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice.
Adams JM; Harris AW; Pinkert CA; Corcoran LM; Alexander WS; Cory S; Palmiter RD; Brinster RL
Nature; 1985 Dec 12-18; 318(6046):533-8. PubMed ID: 3906410
[TBL] [Abstract][Full Text] [Related]
27. Oncogene cooperation in lymphocyte transformation: malignant conversion of E mu-myc transgenic pre-B cells in vitro is enhanced by v-H-ras or v-raf but not v-abl.
Alexander WS; Adams JM; Cory S
Mol Cell Biol; 1989 Jan; 9(1):67-73. PubMed ID: 2784537
[TBL] [Abstract][Full Text] [Related]
28. Partial restoration of B cell development in Jak-3(-/-) mice achieved by co-expression of IgH and E(mu)-myc transgenes.
Dillon SR; Schlissel MS
Int Immunol; 2002 Aug; 14(8):893-904. PubMed ID: 12147626
[TBL] [Abstract][Full Text] [Related]
29. Elevated expression levels of an Ig transgene in mice links the IgH 3' enhancer to the regulation of IgH expression.
Arulampalam V; Furebring C; Samuelsson A; Lendahl U; Borrebaeck C; Lundkvist I; Pettersson S
Int Immunol; 1996 Jul; 8(7):1149-57. PubMed ID: 8757960
[TBL] [Abstract][Full Text] [Related]
30. Involvement of a second lymphoid-specific enhancer element in the regulation of immunoglobulin heavy-chain gene expression.
Libermann TA; Lenardo M; Baltimore D
Mol Cell Biol; 1990 Jun; 10(6):3155-62. PubMed ID: 2111447
[TBL] [Abstract][Full Text] [Related]
31. Strain dependency of B and T lymphoma development in immunoglobulin heavy chain enhancer (E mu)-myc transgenic mice.
Yukawa K; Kikutani H; Inomoto T; Uehira M; Bin SH; Akagi K; Yamamura K; Kishimoto T
J Exp Med; 1989 Sep; 170(3):711-26. PubMed ID: 2504875
[TBL] [Abstract][Full Text] [Related]
32. The E mu-myc transgenic mouse. A model for high-incidence spontaneous lymphoma and leukemia of early B cells.
Harris AW; Pinkert CA; Crawford M; Langdon WY; Brinster RL; Adams JM
J Exp Med; 1988 Feb; 167(2):353-71. PubMed ID: 3258007
[TBL] [Abstract][Full Text] [Related]
33. Growth of E mu-myc transgenic B-lymphoid cells in vitro and their evolution toward autonomy.
Langdon WY; Harris AW; Cory S
Oncogene Res; 1988; 3(3):271-9. PubMed ID: 3144697
[TBL] [Abstract][Full Text] [Related]
34. Ig heavy chain protein controls B cell development by regulating germ-line transcription and retargeting V(D)J recombination.
Schlissel MS; Morrow T
J Immunol; 1994 Aug; 153(4):1645-57. PubMed ID: 8046237
[TBL] [Abstract][Full Text] [Related]
35. Loss of Fas/Apo-1 receptor accelerates lymphomagenesis in E mu L-MYC transgenic mice but not in animals infected with MoMuLV.
Zörnig M; Grzeschiczek A; Kowalski MB; Hartmann KU; Möröy T
Oncogene; 1995 Jun; 10(12):2397-401. PubMed ID: 7784089
[TBL] [Abstract][Full Text] [Related]
36. L-myc and N-myc in hematopoietic malignancies.
Hirvonen H; Hukkanen V; Salmi TT; Pelliniemi TT; Alitalo R
Leuk Lymphoma; 1993 Oct; 11(3-4):197-205. PubMed ID: 8260894
[TBL] [Abstract][Full Text] [Related]
37. Sequences associated with the mouse Smu switch region are important for immunoglobulin heavy chain transgene expression in B cell development.
Luby TM; Sigurdardottir D; Berger ED; Selsing E
Eur J Immunol; 2001 Oct; 31(10):2866-75. PubMed ID: 11592061
[TBL] [Abstract][Full Text] [Related]
38. Transgenic rabbits with lymphocytic leukemia induced by the c-myc oncogene fused with the immunoglobulin heavy chain enhancer.
Knight KL; Spieker-Polet H; Kazdin DS; Oi VT
Proc Natl Acad Sci U S A; 1988 May; 85(9):3130-4. PubMed ID: 2834733
[TBL] [Abstract][Full Text] [Related]
39. Novel control motif cluster in the IgH delta-gamma 3 interval exhibits B cell-specific enhancer function in early development.
Mundt CA; Nicholson IC; Zou X; Popov AV; Ayling C; Brüggemann M
J Immunol; 2001 Mar; 166(5):3315-23. PubMed ID: 11207287
[TBL] [Abstract][Full Text] [Related]
40. A second B cell-specific enhancer 3' of the immunoglobulin heavy-chain locus.
Pettersson S; Cook GP; Brüggemann M; Williams GT; Neuberger MS
Nature; 1990 Mar; 344(6262):165-8. PubMed ID: 2106628
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
